In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Morbi's suspension bridge accident happened because of its new flooring. In the name of renovatio
'I am very impressed with your minister, watch his speeches', UAE minister praises Jaishankar
UAE Minister Praises Jaishankar: United Arab Emirates (UAE) Minister of Artificial Intelligence O
Delhi Chief Minister Rekha Gupta was attacked by a youth. This incident happened when she was con
Special bodyguards accompany on foreign tours to collect excreta of Vladimir Putin: Report
When Russian President Vladimir Putin goes on a foreign tour, he is accompanied by special bodygu
The Election Commission will issue a notification today for the second phase of the Lok Sabha ele
UPMSP 10th, 12th Result 2023: On the one hand, in a fake official release viral on social media,
In Karnataka's Tech City Bengaluru, the police have taken major action against the gang running a
The number of corona infections is decreasing rapidly in Madhya Pradesh. On Sunday, in 70 thousan
Indore Lok Sabha Election 2024 Even before the Lok Sabha elections, Congress suffered a majo
Expressing concern over increasing hostilities in Syria, India on Friday told the United Nations
